Cytotoxicity Studies on 3D Primary Liver Microtissues
16 Jul 2014

This application note describes a proof of concept study to demonstrate the feasibility of a 4-color toxicity assay using living Troglitazone and Staurosporine treated primary human liver microtissues. In this assay, the combination of High Content Imaging with Multimode Detection provides complementary readouts for assessing phenotypic changes and potential toxicological pathways beyond general cytotoxicity markers.

Show    per page
1 of 19     Page  1 2 3  ... Next 
Better Antibody Screening: Reduce Costs. Reduce False Negatives. Improve Success therapeutic antibodies, screening15 Jul 2014Read
PathHunter® β-Arrestin Human and Ortholog GPCR Assays automation, GPCR, liquid handling workstation30 Jun 2014Read
Automated Cell Separation Method Enhances Leukemia Patient Care leukemia5 Jun 2014Read
Metabolic Phenotyping: New Tool for Drug Response Prediction and Personalized Medicine personalized medicine, metabolomics, alzheimers disease27 May 2014Read
Measuring the Metabolic Switch in Cancer Cells apoptosis, cancer, lymphocytes23 May 2014Read
HepatoPac™: A Bioengineered Micro-Liver Platform for Predictive Drug Metabolism and Toxicity Studies liver disease, hepatotoxicity, toxicity22 May 2014Read
Bioenergetic Analysis of Suspension Cells: Hematopoietic Stem Cells and Lymphocytes immunoassay, assay development22 May 2014Read
Quicker Identification of Gram-Positive Cocci in Clusters in Patients with Suspected Sepsis sepsis21 May 2014Read
Influence of Heterogeneity of Amino Acid Sequence Varying Considerably on Immunoreactivity Antigen Region of HCV NS5 Protein from Position 2212 to 2313 hepatitis, eccmid21 May 2014Read
The Advantages of EIA with Improved Sensitivity for the Detection of Low Concentrations of HBsAg in Samples with Markers of HCV, HBV or HIV Infections hepatitis, eccmid, HIV/AIDS21 May 2014Read

Popular tags in SelectScience

Buying guides